Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

All harmful effects · people > 18 years of age with a diagnosed deep vein thrombosis

It is very uncertain whether idrabiotaparinux changes all harmful effects compared with idraparinux (very low certainty).

1 finding from 1 review

Pentasaccharides for the treatment of deep vein thrombosis 2017 · Cochrane Headline outcomes only
RR 0.92 [0.83, 1.02]
1 study · 757 participants
Very low